CLINICAL STUDY: INTERVENTIONAL CARDIOLOGY
Sirolimus-eluting stent for treatment of complex in-stent restenosis
The first clinical experience
Muzaffer Degertekin, MD*,
Evelyn Regar, MD*,
Kengo Tanabe, MD*,
Pieter C. Smits, MD, PhD*,
Willem J. van der Giessen, MD, PhD, FACC*,
Stephan G. Carlier, MD, PhD*,
Pim de Feyter, MD, PhD, FACC*,
Jeroen Vos, MD, PhD*,
David P. Foley, MD, PhD, FACC*,
Jurgen M. R. Ligthart, MSc*,
Jeffrey J. Popma, MD, FACC and
Patrick W. Serruys, MD, PhD, FACC*,*
* Thoraxcenter, University Hospital Rotterdam, Rotterdam, The Netherlands
Brigham and Women’s Hospital, Boston, Massachusetts, USA
Manuscript received May 29, 2002;
revised manuscript received July 30, 2002,
accepted August 19, 2002.
* Reprint requests and correspondence: Prof. Patrick W. Serruys, Head of Interventional Department, Thoraxcentre, Bd. 408, University Hospital Dijkzigt, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Serruys{at}card.azr.nl
OBJECTIVES: In this study, we assess the value of sirolimus eluting stent (SES) implantation in patients with complex in-stent restenosis (ISR).
BACKGROUND: The treatment of ISR remains a therapeutic challenge, since many pharmacological and mechanical approaches have shown disappointing results. The SESs have been reported to be effective in de-novo coronary lesions.
METHODS: Sixteen patients with severe, recurrent ISR in a native coronary artery (average lesion length 18.4 mm) and objective evidence of ischemia were included. They received one or more 18 mm Bx VELOCITY SESs (Cordis Waterloo, Belgium). Quantitative angiographic and three-dimensional intravascular ultrasound (IVUS) follow-up was performed at four months, and clinical follow-up at nine months.
RESULTS: The SES implantation (n = 26) was successful in all 16 patients. Four patients had recurrent restenosis following brachytherapy, and three patients had totally occluded vessels preprocedure. At four months follow-up, one patient had died and three patients had angiographic evidence of restenosis (one in-stent and two in-lesion). In-stent late lumen loss averaged 0.21 mm and the volume obstruction of the stent by IVUS was 1.1%. At nine months clinical follow-up, three patients had experienced four major adverse cardiac events (two deaths and one acute myocardial infarction necessitating repeat target vessel angioplasty).
CONCLUSIONS: The SES implantation in patients with severe ISR lesions effectively prevents neointima formation and recurrent restenosis at four months angiographic follow-up.
|
Abbreviations and Acronyms
| | DS | | diameter stenosis | | ISR | | in-stent restenosis | | IVUS | | intravascular ultrasound | | NIH | | neointimal hyperplasia | | QCA | | quantitative coronary angiography | | SES | | sirolimus eluting stent | | TIMI | | Thrombolysis In Myocardial Infarction |
|
This article has been cited by other articles:
|
|
|
|
 
A. E. Rodriguez and R. Waksman
Sirolimus-Eluting Stents or Vascular Brachytherapy for In-Stent Restenosis After 3-Year Follow-Up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) Trial: A Call for Caution?
J. Am. Coll. Cardiol. Intv.,
January 1, 2009;
2(1):
75 - 76.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Habara, K Mitsudo, T Goto, K Kadota, S Fujii, H Yamamoto, H Kato, S Takenaka, Y Fuku, S Hosogi, et al.
The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis
Heart,
September 1, 2008;
94(9):
1162 - 1165.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Romagnoli, G. M. Sangiorgi, J. Cosgrave, E. Guillet, and A. Colombo
Drug-eluting stenting the case for post-dilation.
J. Am. Coll. Cardiol. Intv.,
February 1, 2008;
1(1):
22 - 31.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Matsumoto, J. Shite, T. Shinke, H. Otake, Y. Tanino, D. Ogasawara, T. Sawada, O. L. Paredes, K.-i. Hirata, and M. Yokoyama
Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography
Eur. Heart J.,
April 2, 2007;
28(8):
961 - 967.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Mishkel, A. L. Moore, S. Markwell, M. C. Shelton, and M. E. Shelton
Long-Term Outcomes After Management of Restenosis or Thrombosis of Drug-Eluting Stents
J. Am. Coll. Cardiol.,
January 16, 2007;
49(2):
181 - 184.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Scheller, C. Hehrlein, W. Bocksch, W. Rutsch, D. Haghi, U. Dietz, M. Bohm, and U. Speck
Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter
N. Engl. J. Med.,
November 16, 2006;
355(20):
2113 - 2124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. K. Steigen, M. Maeng, R. Wiseth, A. Erglis, I. Kumsars, I. Narbute, P. Gunnes, J. Mannsverk, O. Meyerdierks, S. Rotevatn, et al.
Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Study
Circulation,
October 31, 2006;
114(18):
1955 - 1961.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Alfonso, M.-J. Perez-Vizcayno, R. Hernandez, A. Bethencourt, V. Marti, J. R. Lopez-Minguez, J. Angel, R. Mantilla, C. Moris, A. Cequier, et al.
A Randomized Comparison of Sirolimus-Eluting Stent With Balloon Angioplasty in Patients With In-Stent Restenosis: Results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) Trial
J. Am. Coll. Cardiol.,
June 6, 2006;
47(11):
2152 - 2160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Roiron, P Sanchez, A Bouzamondo, P Lechat, and G Montalescot
Drug eluting stents: an updated meta-analysis of randomised controlled trials
Heart,
May 1, 2006;
92(5):
641 - 649.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Holmes Jr, P. Teirstein, L. Satler, M. Sketch, J. O'Malley, J. J. Popma, R. E. Kuntz, P. J. Fitzgerald, H. Wang, E. Caramanica, et al.
Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents: The SISR Randomized Trial
JAMA,
March 15, 2006;
295(11):
1264 - 1273.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Serruys, M. J.B. Kutryk, and A. T.L. Ong
Coronary-Artery Stents
N. Engl. J. Med.,
February 2, 2006;
354(5):
483 - 495.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, A. K. Jacobs, M. J. Kern, S. B. King III, D. A. Morrison, W. W. O'Neill, H. V. Schaff, P. L. Whitlow, et al.
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
216 - 235.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, A. K. Jacobs, M. J. Kern, S. B. King III, D. A. Morrison, W. W. O'Neill, H. V. Schaff, P. L. Whitlow, et al.
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
Circulation,
January 3, 2006;
113(1):
156 - 175.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E Iofina, P W Radke, P Skurzewski, P K Haager, R Blindt, K-C Koch, P Hanrath, J vom Dahl, and R Hoffmann
Superiority of sirolimus eluting stent compared with intracoronary {beta} radiation for treatment of in-stent restenosis: a matched comparison
Heart,
December 1, 2005;
91(12):
1584 - 1589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A E Rodriguez, M Rodriguez Alemparte, C F Vigo, C Fernandez Pereira, C Llaurado, D Vetcher, A Pocovi, and J Ambrose
Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial)
Heart,
November 1, 2005;
91(11):
1433 - 1437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F.-J. Neumann, W. Desmet, E. Grube, J. Brachmann, P. Presbitero, P. Rubartelli, A. Mugge, F. Di Pede, D. Fullgraf, W. Aengevaeren, et al.
Effectiveness and Safety of Sirolimus-Eluting Stents in the Treatment of Restenosis After Coronary Stent Placement
Circulation,
April 26, 2005;
111(16):
2107 - 2111.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Fukui, S. Takanashi, and Y. Hosoda
Coronary Endarterectomy and Stent Removal in Patients With In-Stent Restenosis
Ann. Thorac. Surg.,
February 1, 2005;
79(2):
558 - 563.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J M Cotton, K Rance, A Patil, and M R Thomas
Intracoronary brachytherapy for the treatment of complex in-stent restenosis
Heart,
February 1, 2005;
91(2):
231 - 232.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kastrati, J. Mehilli, N. von Beckerath, A. Dibra, J. Hausleiter, J. Pache, H. Schuhlen, C. Schmitt, J. Dirschinger, A. Schomig, et al.
Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis: A Randomized Controlled Trial
JAMA,
January 12, 2005;
293(2):
165 - 171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Alfonso
Should we use the cutting balloon in patients with in-stent restenosis?
J. Am. Coll. Cardiol.,
December 21, 2004;
44(12):
2416 - 2416.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J J Goy, P Urban, C Seydoux, P Couke, E De Benedetti, and J C Stauffer
Vascular brachytherapy versus sirolimus eluting stents for the treatment of in-stent restenosis: a prospective registry
Heart,
December 1, 2004;
90(12):
1491 - 1492.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Waksman, A. E. Ajani, A. D. Pichard, R. Torguson, E. Pinnow, D. Canos, L. F. Satler, K. M. Kent, P. Kuchulakanti, C. Pappas, et al.
Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: The Oral Rapamune to Inhibit Restenosis (ORBIT) study
J. Am. Coll. Cardiol.,
October 6, 2004;
44(7):
1386 - 1392.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F Saia, P A Lemos, C A Arampatzis, A Hoye, M Degertekin, K Tanabe, G Sianos, P C Smits, W J van der Giessen, P J de Feyter, et al.
Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry
Heart,
October 1, 2004;
90(10):
1183 - 1188.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Alfonso
Optimal Implantation Strategies Using Drug-Eluting Stents for In-Stent Restenosis: Do We Know the Answer?
Circulation,
September 14, 2004;
110(11):
e302 - e302.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W Radke, S. Kobella, A. Kaiser, A. Franke, D. Schubert, E. Grube, P. Hanrath, and R. Hoffmann
Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary {beta}-radiation therapy
Eur. Heart J.,
June 1, 2004;
25(11):
920 - 925.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Holmes Jr
How Many Grails Do We Need?
Circulation,
May 11, 2004;
109(18):
2158 - 2159.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H Chong and J. W. Cheng
Early Experiences and Clinical Implications of Restenosis and Drug-Eluting Stents: Part 2
Ann. Pharmacother.,
May 1, 2004;
38(5):
845 - 852.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Lemos, A. Hoye, D. Goedhart, C. A. Arampatzis, F. Saia, W. J. van der Giessen, E. McFadden, G. Sianos, P. C. Smits, S. H. Hofma, et al.
Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study
Circulation,
March 23, 2004;
109(11):
1366 - 1370.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Fujii, G. S. Mintz, Y. Kobayashi, S. G. Carlier, H. Takebayashi, T. Yasuda, I. Moussa, G. Dangas, R. Mehran, A. J. Lansky, et al.
Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis
Circulation,
March 9, 2004;
109(9):
1085 - 1088.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E M Wong, C Pawsey, and H C Lowe
Evidence for "lumen sealing" with sirolimus eluting stents in the treatment of complex coronary artery dissection
Heart,
March 1, 2004;
90(3):
e13 - 13.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Lemos, P. W. Serruys, R. T. van Domburg, F. Saia, C. A. Arampatzis, A. Hoye, M. Degertekin, K. Tanabe, J. Daemen, T. K.K. Liu, et al.
Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the "Real World": The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry
Circulation,
January 20, 2004;
109(2):
190 - 195.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Degertekin, P. A. Lemos, C. H. Lee, K. Tanabe, J.E. Sousa, A. Abizaid, E. Regar, G. Sianos, W. J. van der Giessen, P. J. de Feyter, et al.
Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions
Eur. Heart J.,
January 1, 2004;
25(1):
32 - 38.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y. W. Lew, and S. Tsimikas
Highlights of the year in JACC 2003
J. Am. Coll. Cardiol.,
December 17, 2003;
42(12):
2156 - 2166.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Waksman, R. Lew, A. E. Ajani, A. D. Pichard, L. F. Satler, K. M. Kent, R. Chan, R. L. White, W. O. Suddath, E. Pinnow, et al.
Repeat Intracoronary Radiation for Recurrent In-Stent Restenosis in Patients Who Failed Intracoronary Radiation
Circulation,
August 12, 2003;
108(6):
654 - 656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Lemos, F. Saia, J. M.R. Ligthart, C. A. Arampatzis, G. Sianos, K. Tanabe, A. Hoye, M. Degertekin, J. Daemen, E. McFadden, et al.
Coronary Restenosis After Sirolimus-Eluting Stent Implantation: Morphological Description and Mechanistic Analysis From a Consecutive Series of Cases
Circulation,
July 22, 2003;
108(3):
257 - 260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Lemos, P. W. Serruys, and J. E. Sousa
Drug-Eluting Stents: Cost Versus Clinical Benefit
Circulation,
June 24, 2003;
107(24):
3003 - 3007.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Sirolimus-Eluting Stents for In-Stent Restenosis?
Journal Watch Cardiology,
March 7, 2003;
2003(307):
4 - 4.
[Full Text]
|
|
|
|
|
|
|
K. E. Bornfeldt
The Cyclin-Dependent Kinase Pathway Moves Forward
Circ. Res.,
March 7, 2003;
92(4):
345 - 347.
[Full Text]
[PDF]
|
|
|
|
